Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Delcath Systems (DCTH)
NASDAQ:DCTH
Delcath Systems (DCTH) Stock Price & Analysis
481 Followers
DCTH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.34 - $7.99
Previous Close$7.29
Volume75.50K
Average Volume (3M)53.44K
Market Cap
$77.43M
Enterprise Value$62.81M
Total Cash (Recent Filing)$24.27M
Total Debt (Recent Filing)$9.66M
Price to Earnings (P/E)-2.0
Beta1.01
Next Earnings
Aug 17, 2023EPS Estimate
-$0.52Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.73
Shares Outstanding10,620,813
10 Day Avg. Volume90,428
30 Day Avg. Volume53,442
Standard Deviation0.22
R-Squared0.04
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)-6.47
Price to Sales (P/S)129.69
Price to Cash Flow (P/CF)-5.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue20.20
Enterprise Value/Gross Profit30.90
Enterprise Value/Ebitda-1.86
Forecast
1Y Price Target
$15.33Price Target Upside110.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Delcath Systems News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DCTH FAQ
What was Delcath Systems’s price range in the past 12 months?
Delcath Systems lowest stock price was $2.34 and its highest was $7.99 in the past 12 months.
What is Delcath Systems’s market cap?
Currently, no data Available
When is Delcath Systems’s upcoming earnings report date?
Delcath Systems’s upcoming earnings report date is Aug 17, 2023 which is in 74 days.
How were Delcath Systems’s earnings last quarter?
Delcath Systems released its earnings results on May 12, 2023. The company reported -$0.7 earnings per share for the quarter, missing the consensus estimate of -$0.612 by -$0.088.
Is Delcath Systems overvalued?
According to Wall Street analysts Delcath Systems’s price is currently Undervalued.
Does Delcath Systems pay dividends?
Delcath Systems does not currently pay dividends.
What is Delcath Systems’s EPS estimate?
Delcath Systems’s EPS estimate is -$0.52.
How many shares outstanding does Delcath Systems have?
Delcath Systems has 10,620,813 shares outstanding.
What happened to Delcath Systems’s price movement after its last earnings report?
Delcath Systems reported an EPS of -$0.7 in its last earnings report, missing expectations of -$0.612. Following the earnings report the stock price went down -0.826%.
Which hedge fund is a major shareholder of Delcath Systems?
Among the largest hedge funds holding Delcath Systems’s share is Deerfield Management Company, LP. It holds Delcath Systems’s shares valued at N/A.
---
Delcath Systems Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$15.33 (110.29% Upside)
$15.33 (110.29% Upside)
Hedge Fund Trend
Decreased
By 486.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $95.1K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
63.82%
12-Months-Change
Fundamentals
Return on Equity
-677.65%
Trailing 12-Months
Asset Growth
12.01%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Delcath Systems
Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers. It develops and commercializes CHEMOSAT and Melphalan Hydrochloride for Injection, which is a proprietary product used with the Delcath Hepatic Delivery System. The company was founded in August 1988 and is headquartered in New York, NY.
---
Top 5 ETFs holding DCTH
Vanguard Total Stock Market ETF
$1.47M
Up to five ETFs with an Outperform Smart Score that hold DCTH. The ETFs are listed according to market value of DCTH within the ETF
---
Brainstorm Cell Therapeutics
―
Cyclacel Pharmaceuticals
―
ImmunoGen
―
Infinity Pharma
―
---